Hayashi, Yoshinori
Makino, Tomoki http://orcid.org/0000-0001-7918-4217
Sato, Eiichi
Ohshima, Kenji http://orcid.org/0000-0003-1114-386X
Nogi, Yuya
Kanemura, Takashi
Honma, Keiichiro
Yamashita, Kotaro
Saito, Takuro
Tanaka, Koji
Yamamoto, Kazuyoshi
Takahashi, Tsuyoshi http://orcid.org/0000-0003-2397-1478
Kurokawa, Yukinori
Miyata, Hiroshi
Nakajima, Kiyokazu
Wada, Hisashi http://orcid.org/0000-0002-5444-6193
Morii, Eiichi http://orcid.org/0000-0001-8490-3650
Eguchi, Hidetoshi
Doki, Yuichiro
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (22K07278)
Takeda Science Foundation
Princess Takamatsu Cancer Research Fund
Japan Research Foundation for Clinical Pharmacology
Article History
Received: 3 December 2022
Revised: 6 March 2023
Accepted: 14 March 2023
First Online: 4 April 2023
Competing interests
: The authors declare no competing interests.
: This study was approved by the Institutional Review Board of Osaka University Hospital (No. 20056). The secondary use of tissue and data in this study are covered by an opt-out regimen conform, and written informed consent was obtained from each patient through the comprehensive consent form in the facilities. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.